Cell removal with supercritical carbon dioxide for acellular artificial tissue

Journal of Chemical Technology and Biotechnology

Volumn 83, Issue 6, 2008, Pages 943-949

  Sawada, K ^a   Terada, D ^b   Yamaoka, T ^c   Kitamura, S ^c   Fujisato, T ^b  

^a Osaka Seikei College   (Japan)

^b OSAKA INSTITUTE OF TECHNOLOGY   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Aorta; Decellularization; Extraction; Supercritical carbon dioxide

Indexed keywords

BIOCHEMISTRY; CARBON DIOXIDE; CELLS; EXTRACTION; SUPERCRITICAL FLUIDS;

ACELLULAR ARTIFICIAL TISSUE; DECELLULARIZATION; SUPERCRITICAL CARBON DIOXIDE;

TISSUE;

CARBON DIOXIDE; PHOSPHOLIPID; SURFACTANT;

BIOCHEMISTRY; CARBON DIOXIDE; CELLS; EXTRACTION; SUPERCRITICAL FLUIDS; TISSUE;

ANIMAL TISSUE; AORTA; ARTICLE; ARTIFICIAL ORGAN; CELL ISOLATION; CELL MEMBRANE; CELL NUCLEUS; CONTROLLED STUDY; NONHUMAN; STRENGTH; SUPERCRITICAL FLUID EXTRACTION; SWINE; TISSUE PRESERVATION; TISSUE REGENERATION;

EID: 44649115904     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.1899     Document Type: Article

References (27)

1. Badylak SF, Kochupura PV, Cohen IS, Doronin SV, Saltman AE, Gilbert TW, et al., The use of extracellular matrix as an inductive scaffold for the partial replacement of functional myocardium. Cell Transplant 15:S29-S40 (2006).
2. Deguchi K, Tsuru K, Hayashi T, Takaishi M, Nagahara M, Nagotani S, et al., Implantation of a new porous gelatin-siloxane hybrid into a brain lesion as a potential scaffold for tissue regeneration. J Cereb Blood Flow Metab 26:1263-1273 (2006).
3. Triolo F and Gridelli B, End-stage organ failure: will regenerative medicine keep its promise? Cell Transplant 15:S3-S10 (2006).
4. Schoen FJ, New frontiers in the pathology and therapy of heart valve disease. Cardiovasc Pathol 15:271-279 (2006).
5. Schoen FJ, Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc Pathol 14:189-194 (2005).
6. Webb AR, Yang J and Ameer GA, Biodegradable polyester elastomers in tissue engineering. Expert Opin Biol Ther 4:801-812 (2004).
7. Nuttelman CR, Henry SM and Anseth KS, Synthesis and characterization of photocrosslinkable, degradable poly(vinyl alcohol)-based tissue engineering scaffolds. Biomaterials 23:3617-3626 (2002).
8. Stock UA and Mayer JE Jr, Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J Long Term Eff Med Implants 11:249-260 (2001).
9. Kim WG, Park JK, Park YN, Hwang CM, Jo YH, Min BG, et al., Tissue-engineered heart valve leaflets: an effective method for seeding autologous cells on scaffolds. Int J Artif Organs 23:624-628 (2000).
10. Kasimir MT, Rieder E, Seebacher G, Silberhumer G, Wolner F, Weigel G, et al., Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 26:421-427 (2003).
11. Schmidt CE and Baier JM, Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 21:2215-2231 (2000).
12. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R and Clarke D, The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 11:194-200 (1999).
13. Allaire E, Bruneval P, Mandet C, Becquemin JP and Michel JB, The immunogenicity of the extracellular matrix in arterial xenografts. Surgery 122:73-81 (1997).
14. Korossis SA, Booth C, Wilcox HE, Watterson KG, Kearney JN, Fisher J, et al., Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J Heart Valve Dis 11:463-471 (2002).
15. Kim WG, Park JK and Lee WY, Tissue-engineered heart valve leaflets: an effective method of obtaining acellularized valve xenografts, Int J Artif Organs 25:791-797 (2002).
16. Booth C, Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Fisher J, et al., Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 11:457-462 (2002). i
17. Korossis SA, Wilcox HE, Watterson KG, Kearney JN, Ingham E and Fisher J, In-vitro assessment of the functional performance of the decellularized intact porcine aortic root. J Heart Valve Dis 14:408-421 (2005).
18. Kasimir MT, Weigel G, Sharma J, Rieder E, Seebacher G, Wolner E, et al., The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost 94:562-567 (2005).
19. Meyer SR, Chiu B, Churchill TA, Zhu L, Lakey JR and Ross DB, Comparison of aortic valve allograft decellularization techniques in the rat. J Biomed Mater Res A 79:254-262 (2006).
20. Rieder E, Seebacher G, Kasimir MT, Eichmair E, Winter B, Dekan B, et al., Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111:2792-2797 (2005).
21. Fujisato T, Kishida A, Funamoto S, Nakatani T and Kitamura S. Jpn Kokai Tokkyo Koho JP 2004-97552.
22. Dean IR and Khundker S, Extraction of pharmaceuticals using pressurised carbon dioxide. J Pharm Biomed Anal 15:875-886 (1997).
23. Reverchon E and De MI, Supercritical fluid extraction and fractionation of natural matter. J Supercrit Fluid 38:146-166 (2006).
24. Takayama M, Itoh S, Nagasaki T and Tanimizu I, A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 79:93-98 (1977).
25. Mcfetridge PS, Daniel JW, Bodamyali T, Horrocks M and Chaudhuri JB, Preparation of porcine carotid arteries for vascular tissue engineering applications. J Biomed Mater Res 70A:224-234 (2004).
26. Mertsching H, Schanz J, Walles T, Hofmann M and Knapp WH, Engineering of a vascularized scaffold for artificial tissue and organ generation. Biomaterials 26:6610-6617 (2005).
27. Gilbert TW, Sellaro TL and Badylak SF, Decellularization of tissues and organs. Biomaterials 27:3675-3683 (2006).